Kazuyo Ohta

Title: Kazuyo Ohta: Innovator in Antibiotic Development

Introduction

Kazuyo Ohta is a prominent inventor based in Shizuoka, Japan. She has made significant contributions to the field of antibiotic research, particularly in developing novel compounds with enhanced antibacterial properties. Her work has the potential to address critical challenges in treating infectious diseases.

Latest Patents

Kazuyo Ohta holds 2 patents, showcasing her innovative approach to antibiotic development. Her latest patents include:

1. **23-O-substituted carbamoyl-23-demycinosyldesmycosin** - This compound exhibits stronger antibacterial activity compared to known macrolide antibiotics such as erythromycin and oleandomycin. It is effective against macrolide-resistant strains and is stable in vivo, making it suitable for treating infectious diseases and as a feed additive.

2. **3-O-acyl-4'-deoxydesmycosin derivatives** - These novel derivatives demonstrate antibiotic utility against both Gram-positive and Gram-negative bacteria. They are produced by acylating the hydroxyl group at position-3 of the corresponding intermediate while protecting other hydroxyl groups.

Career Highlights

Kazuyo Ohta is associated with Toyo Jozo Kabushiki Kaisha, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of antibiotic research.

Collaborations

Kazuyo has collaborated with notable colleagues, including Tatsuro Fujiwara and Takao Hirano, contributing to the advancement of antibiotic research.

Conclusion

Kazuyo Ohta's contributions to antibiotic development highlight her role as an innovator in the field. Her patents reflect her commitment to addressing the challenges posed by antibiotic resistance and improving treatment options for infectious diseases.